Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.
about
The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.Overview on the complexity of androgen receptor-targeted therapy for prostate cancerOverexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamiErianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway
P2860
Q35922961-57A7032D-C822-48E2-BAC2-B334140BED15Q36481398-469C0279-7DCB-49F9-AD31-5219CF30FED7Q38364166-27916E79-3550-4443-8FAD-60572D3BCE3BQ38797305-871315CD-7DB7-45A9-A839-00F2E35F60A5Q38833700-F57A5031-839B-492A-9534-129CC9E743F7Q49959247-1778EABF-8227-49E0-9E0D-39B453830595Q51126611-51327C5B-7879-4F9D-8BD4-2A4E2DB87C0CQ53627379-4F1900DF-6234-4CBC-80F3-3829E3A295C3Q55004240-B0253283-47EE-4636-AC18-5266F2460588Q58800850-79D02082-CAE0-4337-A1AF-F75934F293D4
P2860
Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Overexpression of HepaCAM inhi ...... signaling in prostate cancer.
@en
type
label
Overexpression of HepaCAM inhi ...... signaling in prostate cancer.
@en
prefLabel
Overexpression of HepaCAM inhi ...... signaling in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Overexpression of HepaCAM inhi ...... signaling in prostate cancer.
@en
P2093
Chunli Luo
Hongfei Du
Xiaohou Wu
Xiaorong Wang
Xuedong Song
P2860
P304
P356
10.1002/PROS.22817
P577
2014-05-08T00:00:00Z